C07C 215/54
Linked by carbon chains having at least three carbon atoms between the
Official title: linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
C07C215/54 (Linked by carbon chains having at least three carbon atoms between the) appears on 94 US grants and 94 published applications in this corpus.
Search patents in C07C- Granted patents
- 94
- Published applications
- 94
- Assignees
- 71
- Inventors
- 257
- Latest grant
- 29 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 4 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2001 | 6 | 1 |
| 2002 | 1 | 5 |
| 2003 | 3 | 6 |
| 2004 | 5 | 5 |
| 2005 | 2 | 4 |
| 2006 | 4 | 7 |
| 2007 | 3 | 3 |
| 2008 | 6 | 4 |
| 2009 | 2 | 4 |
| 2010 | 0 | 5 |
| 2011 | 2 | 4 |
| 2012 | 2 | 5 |
| 2013 | 2 | 5 |
| 2014 | 1 | 8 |
| 2015 | 5 | 3 |
| 2016 | 6 | 2 |
| 2017 | 1 | 6 |
| 2018 | 3 | 4 |
| 2019 | 1 | 3 |
| 2020 | 2 | 3 |
| 2021 | 1 | 4 |
| 2022 | 2 | 1 |
| 2023 | 1 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Co-crystals of lithium benzoate and uses thereof29 Aug 2023US 11,739,046 B2SyneuRx International (Taiwan) Corp.
- Compositions for the treatment of pulmonary fibrosis2 Aug 2022US 11,401,245 B2Vectus Biosystems Limited
- D3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease8 Mar 2022US 11,266,612 B2Drexel University
- Compositions for the treatment of pulmonary fibrosis16 Feb 2021US 10,919,863 B2Vectus Biosystems Limited
- Co-crystals of lithium benzoate and uses thereof27 Oct 2020US 10,815,184 B2SyneuRx International (Taiwan) Corp.
- Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride8 Jun 2023US 2023/0174458 A1Gruenenthal GmbH
- Pharmaceutical composition for preventing or treating muscular weakness-related diseases comprising alverine, 4-hydroxy alverine, derivative thereof, or pharmaceutically acceptable salt thereof18 May 2023US 2023/0149326 A1Aventi Inc.
- Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease28 Jul 2022US 2022/0233475 A1Drexel University
- Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride26 Aug 2021US 2021/0261492 A1GrüNenthal GmbH
- A novel process for the preparation of tapentadol19 Aug 2021US 2021/0253513 A1Pharmathen S. A.
Most cited
By later US patents
- 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects90US 6,248,737 B1Gruenenthal GmbH · 2001
- 2-amino-1,3-propanediol compound and immunosuppressant76US 5,604,229 ATaito Co., Ltd. · 1997
- Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases45US 6,071,970 ANPS Pharmaceuticals, Inc. · 2000
- 3,3-diphenylpropylamines and pharmaceutical compositions thereof40US 5,382,600 APharmacia Aktiebolag · 1995
- Process to prepare tolterodine34US 5,922,914 APharmacia & Upjohn Company · 1999